Key Points
- Globe Life CFO Thomas Peter Kalmbach sold 7,936 shares on May 22 at an average price of $156.59, totaling about $1.24 million. After the sale, he still owned 50,496 shares worth roughly $7.9 million, and the transaction cut his position by 13.58%.
- Kalmbach has been actively selling shares recently, including additional sales on May 8, May 11, and May 19. Those trades were also disclosed in SEC filings.
- Globe Life recently reported mixed financial results: earnings per share of $3.43 slightly missed expectations, while revenue matched estimates at $1.56 billion and rose 5.3% year over year. The company also announced a quarterly dividend of $0.33 per share and has a consensus analyst rating of “Moderate Buy.”
Globe Life Inc. (NYSE:GL - Get Free Report) CFO Thomas Peter Kalmbach sold 7,936 shares of the company's stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24. Following the completion of the transaction, the chief financial officer directly owned 50,496 shares in the company, valued at approximately $7,907,168.64. The trade was a 13.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The stock was sold at an average price of $156.61, for a total transaction of $1,864,128.83.
- On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The stock was sold at an average price of $152.02, for a total transaction of $1,792,315.80.
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05.
Globe Life Trading Up 0.4%
Globe Life stock opened at $156.97 on Wednesday. The stock has a market cap of $12.19 billion, a P/E ratio of 10.86 and a beta of 0.50. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a fifty-two week low of $116.73 and a fifty-two week high of $157.92. The firm's fifty day moving average price is $147.96 and its 200-day moving average price is $142.31.
Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts' consensus estimates of $3.46 by ($0.03). The firm had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The firm's revenue was up 5.3% compared to the same quarter last year. During the same period in the prior year, the company earned $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities research analysts forecast that Globe Life Inc. will post 15.57 earnings per share for the current fiscal year.
Globe Life Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life's dividend payout ratio is currently 9.13%.
Analysts Set New Price Targets
A number of research analysts recently commented on the company. Keefe, Bruyette & Woods reissued a "moderate buy" rating and issued a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Piper Sandler increased their target price on Globe Life from $167.00 to $175.00 and gave the company an "overweight" rating in a research note on Tuesday. Weiss Ratings raised Globe Life from a "buy (b-)" rating to a "buy (b)" rating in a research note on Wednesday, May 13th. Wells Fargo & Company increased their target price on Globe Life from $171.00 to $172.00 and gave the company an "overweight" rating in a research note on Friday, April 10th. Finally, Evercore set a $157.00 target price on Globe Life in a research note on Wednesday, February 18th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, Globe Life has a consensus rating of "Moderate Buy" and a consensus price target of $174.11.
Read Our Latest Stock Report on Globe Life
Institutional Trading of Globe Life
Several institutional investors have recently added to or reduced their stakes in the business. Compound Planning Inc. boosted its holdings in shares of Globe Life by 4.3% during the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company's stock worth $275,000 after purchasing an additional 82 shares during the period. Root Financial Partners LLC boosted its holdings in shares of Globe Life by 23.3% during the first quarter. Root Financial Partners LLC now owns 439 shares of the company's stock worth $61,000 after purchasing an additional 83 shares during the period. Transcend Capital Advisors LLC boosted its holdings in shares of Globe Life by 3.9% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company's stock worth $317,000 after purchasing an additional 84 shares during the period. Natural Investments LLC boosted its holdings in shares of Globe Life by 2.6% during the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company's stock worth $482,000 after purchasing an additional 87 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in shares of Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company's stock worth $231,000 after purchasing an additional 87 shares during the period. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
About Globe Life
(
Get Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
